Key facts
- This page summarizes ACORN BIOVENTURES, L.P.'s Form 3 filing for OnKure Therapeutics, Inc. (OKUR).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 09 Oct 2024, 16:15.
ACORN BIOVENTURES, L.P. - 04 Oct 2024 Form 3 Insider Report for OnKure Therapeutics, Inc. (OKUR)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- OKUR
- Reported as of
- 04 Oct 2024
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 09 Oct 2024, 16:15:04 UTC
- Next SEC filing
- 19 May 2025
- Source filing
- View source filing
- Reporting owner signature
- ACORN BIOVENTURES, L.P., By: Acorn Capital Advisors GP, LLC, its general partner, By: /s/ Anders Hove, Manager
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
ACORN BIOVENTURES, L.P. filed Form 3 for OnKure Therapeutics, Inc. (OKUR) on 09 Oct 2024.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OKUR
holding
Class A Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,439,674
- Date
- 04 Oct 2024
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Shares held directly by Acorn Bioventures, L.P. ("Acorn"). Acorn Capital Advisors GP, LLC ("Acorn GP") is the general partner of Acorn Bioventures, L.P. Anders Hove is the manager of Acorn GP. Each of Acorn GP and Mr. Hove disclaims beneficial ownership of disclaims beneficial ownership of the securities reported herein for purposes of Section 16 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its or his pecuniary interest therein, if any. This report shall not be deemed an admission that any of the Reporting Persons is a beneficial owner of such securities for the purpose of Section 16 of the Exchange Act, or for any other purpose.